Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
Medical University of South Carolina
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)